AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
58.97
-0.33 (-0.56%)
Oct 23, 2026, 4:00 PM EDT - Market closed
AtriCure Market Cap
AtriCure has a market cap or net worth of $3 billion as of October 23, 2026. It is the 5,134th most valuable company in the world and the 1,504th biggest in the United States. Its market cap has increased by 62.63% in one year.
Market Cap
3.00B
Enterprise Value
2.91B
1-Year Change
62.63%
Global Rank
Country Rank
#1,504 United States
Category
ChartMarket Cap Chart
Since August 5, 2005, AtriCure's market cap has increased from $167.60M to $3.00B, an increase of 1,689.73%. That is a compound annual growth rate of 14.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.00B | 52.51% |
| Dec 31, 2025 | 1.97B | 32.01% |
| Dec 31, 2024 | 1.49B | -11.92% |
| Dec 29, 2023 | 1.69B | -18.05% |
| Dec 30, 2022 | 2.06B | -35.37% |
| Dec 31, 2021 | 3.19B | 27.42% |
| Dec 31, 2020 | 2.51B | 94.93% |
| Dec 31, 2019 | 1.29B | 9.07% |
| Dec 31, 2018 | 1.18B | 87.48% |
| Dec 29, 2017 | 628.80M | -3.34% |
| Dec 30, 2016 | 650.50M | -10.02% |
| Dec 31, 2015 | 722.90M | 31.84% |
| Dec 31, 2014 | 548.30M | 39.66% |
| Dec 31, 2013 | 392.60M | 241.09% |
| Dec 31, 2012 | 115.10M | -36.16% |
| Dec 30, 2011 | 180.30M | 12.62% |
| Dec 31, 2010 | 160.10M | 73.08% |
| Dec 31, 2009 | 92.50M | 192.72% |
| Dec 31, 2008 | 31.60M | -82.95% |
| Dec 31, 2007 | 185.30M | 70.16% |
| Dec 29, 2006 | 108.90M | -15.25% |
| Dec 30, 2005 | 128.50M | -23.33% |
| Aug 5, 2005 | 167.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merit Medical Systems | 5.57B |
| Stevanato Group | 5.32B |
| MiniMed Group | 5.16B |
| ICU Medical | 4.17B |
| Envista Holdings | 3.79B |
| Pulse Biosciences | 3.78B |
| Warby Parker | 3.20B |
| LeMaitre Vascular | 1.93B |